Ceramides as a New Biomarker for Cardiovascular Risk Prediction

<p>Ceramides as a New Biomarker for Cardiovascular Risk Prediction</p> <p>Guest: Vlad C. Vasile, M.D., Ph.D. (<a href='https://twitter.com/VladCVasile'>@VladCVasile</a>)</p> <p>Host: Stephen L. Kopecky, M.D. (<a href='http://twitter.com/DrSteveKopecky'>@DrSteveKopecky</a>)</p> <p>Joining us today to discuss ceramides is Vlad C. Vasile, M.D., Ph.D., a preventive cardiologist and co-director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, Minnesota.</p> <p>Specific topics discussed:</p> <ul><li>What are ceramides?</li> <li>When do you use ceramides?</li> <li>Do you follow up on ceramides?</li> </ul> <p>Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at <a href='https://cveducation.mayo.edu'>https://cveducation.mayo.edu</a> or on Twitter <a href='https://www.twitter.com/mayocliniccv'>@MayoClinicCV</a>.</p> <p>No CME credit offered for this episode.</p> <p>Podcast episode transcript found <a href='https://mcdn.podbean.com/mf/web/jwzcb8/P-MayoCV22_Ceramides_Vasile_CC_Transcript_Final.pdf'>here</a>.</p>